News Quantified

NTRP – nexttrip, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group [Yahoo! Finance Canada]

NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group [Yahoo! Finance]

NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group

NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance

NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators [Yahoo! Finance]

Form S-1/A NextTrip, Inc.

Form 8-K NextTrip, Inc. For: Dec 09

Form S-1/A NextTrip, Inc.

Form 8-K NextTrip, Inc. For: Nov 11

Form 10-Q NextTrip, Inc. For: Aug 31

Top News Gainers

1/21 Form 8-K Neurotrope, Inc. For: Jan 17 14.2%

8/5 Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results 11.8%

8/5 Form 8-K Neurotrope, Inc. For: Aug 05 10.6%

6/18 Neurotrope Inc (NASDAQ: NTRP) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock. 5.8%

8/21 Neurotrope Inc (NASDAQ: NTRP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.50 price target on the stock. 5.6%

7/17 Neurotrope's Bryostatin Is Unlikely To Produce Significant Cognitive Efficacy [Seeking Alpha] 3.8%

6/5 Form DEF 14A Neurotrope, Inc. For: Jul 23 3.2%

5/30 Neurotrope to Present at the LD Micro 9th Annual Invitational Conference on June 4, 2019 2.9%

10/25 Neurotrope Inc (NASDAQ: NTRP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.9%

6/24 Neurotrope CEO to Present at the Maxim Group Key Opinion Leader Discussion on Alzheimer's Disease on June 26th, 2019 2.6%

Top News Decliners

1/22 Neurotrope, Inc. Announces $18 Million Registered Direct Offering -47.6%

3/13 Form 10-K Neurotrope, Inc. For: Dec 31 -11.7%

8/13 Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy -11.5%

10/8 Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value -9.3%

7/11 Neurotrope to Present at the Alzheimer's Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be Presented -9.0%

8/26 Form S-8 Neurotrope, Inc. -9.0%

3/24 Form 4 Neurotrope, Inc. For: Mar 20 Filed by: Bernstein Bruce -6.8%

8/8 Q2/2019 6/30/2019 EPS 0.310 ZacksConsensus -0.380 ActVsEst 0.690 - Beat -5.4%

12/16 Form 4 Neurotrope, Inc. For: Dec 13 Filed by: Ryan Charles S. -4.7%

4/17 Form S-3 Neurotrope, Inc. -4.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day